22 Dec 2020

Interview with Alastair Smith about license agreement with Astrea Bioseparations

Diagnostics | Investors

21 Dec 2020

License Agreement with Astrea Bioseparations

Diagnostics | Investors

23 Nov 2020

SARS-CoV-2 Rapid Antigen Test Update

Diagnostics | Investors

27 Oct 2020

ShareBuyers Interview with Alastair Smith

Diagnostics | Investors | Therapeutics

30 Sep 2020

Launch of SARS-CoV-2 BAMS^TM Research Test

Diagnostics | Investors

29 Sep 2020

Interim Results for the Period Ended 30 June 2020 – webinar presentation

Investors

28 Sep 2020

Interim Results for the Period Ended 30 June 2020

Investors

14 Sep 2020

Notice of Results and Investor Presentation

Investors

07 Sep 2020

Alastair Smith gives more detail on the SARS-CoV-2 ELISA laboratory test

Diagnostics | Investors

07 Sep 2020

Avacta to Launch SARS-CoV-2 ELISA Laboratory Test

Diagnostics | Investors